APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Abortus Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Brucella Abortus Vaccine Industry Growth and Trends Forecast to 2032

20 December 2025127 pages

Choose your research edition.

Industry ResearchBrucella Abortus Vaccine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Abortus Vaccine Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Brucella Abortus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Abortus Vaccine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Abortus Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Brucella Abortus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brucella Abortus Vaccine include Zoetis, Qilu Animal Health, Merck Animal Health, Vetal, VECOL, Tecnovax, SYVA Laboratorios, Onderstepoort Biological Products and Merial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Brucella Abortus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brucella Abortus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brucella Abortus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brucella Abortus Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Brucella Abortus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brucella Abortus Vaccine Market by Company

Zoetis

Qilu Animal Health

Merck Animal Health

Vetal

VECOL

Tecnovax

SYVA Laboratorios

Onderstepoort Biological Products

Merial

JOVAC

Instituto Rosenbusch

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals

Hester Biosciences

Dollvet

CZ Veterinaria

Colorado Serum Company

CEVA

Centro Diagnostico Veterinario

CAVAC

Biovet

Biogenesis Bago

Brucella Abortus Vaccine Segment by Type

Vector Vaccines

Subunit Vaccines

DNA Vaccines

B. Abortus Recombinant Mutants

Others

Brucella Abortus Vaccine Segment by Application

Pigs

Sheep

Cattles

Others

Brucella Abortus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Abortus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Abortus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Abortus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Brucella Abortus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vector Vaccines Table 2. Major Company of Subunit Vaccines Table 3. Major Company of DNA Vaccines Table 4. Major Company of B. Abortus Recombinant Mutants Table 5. Major Company of Others Table 6. Global Brucella Abortus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 8. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2021-2026) Table 9. Global Brucella Abortus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 10. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2021-2026) Table 11. Global Brucella Abortus Vaccine Price by Type (2021-2026) & (US$/unit) Table 12. Global Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 13. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2027-2032) Table 14. Global Brucella Abortus Vaccine Sales by Type (2027-2032) & (US$ Million) Table 15. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2027-2032) Table 16. Global Brucella Abortus Vaccine Price by Type (2027-2032) & (US$/unit) Table 17. North America Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 18. North America Brucella Abortus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 20. Europe Brucella Abortus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Brucella Abortus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 24. Latin America Brucella Abortus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Brucella Abortus Vaccine Sales by Type (2021-2026) & (US$ Million) Table 27. Brucella Abortus Vaccine Industry Trends Table 28. Brucella Abortus Vaccine Industry Drivers Table 29. Brucella Abortus Vaccine Industry Opportunities and Challenges Table 30. Brucella Abortus Vaccine Industry Restraints Table 31. Global Brucella Abortus Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Brucella Abortus Vaccine Revenue Market Share by Company (2021-2026) Table 33. Global Brucella Abortus Vaccine Sales by Company (2021-2026) & (k units) Table 34. Global Brucella Abortus Vaccine Sales Share by Company (2021-2026) Table 35. Global Brucella Abortus Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Brucella Abortus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Brucella Abortus Vaccine Major Company Production Sites and Headquarters Table 38. Global Brucella Abortus Vaccine Company, Product Type & Application Table 39. Global Brucella Abortus Vaccine Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Brucella Abortus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Brucella Abortus Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Brucella Abortus Vaccine Sales by Region (2021-2026) & (k units) Table 44. Global Brucella Abortus Vaccine Sales Market Share in Volume by Region (2021-2026) Table 45. Global Brucella Abortus Vaccine Sales by Region (2021-2026) & (US$ Million) Table 46. Global Brucella Abortus Vaccine Sales Market Share in Value by Region (2021-2026) Table 47. Global Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Brucella Abortus Vaccine Sales by Region (2027-2032) & (k units) Table 49. Global Brucella Abortus Vaccine Sales Market Share in Volume by Region (2027-2032) Table 50. Global Brucella Abortus Vaccine Sales by Region (2027-2032) & (US$ Million) Table 51. Global Brucella Abortus Vaccine Sales Market Share in Value by Region (2027-2032) Table 52. Global Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Brucella Abortus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 55. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2021-2026) Table 56. Global Brucella Abortus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 57. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2021-2026) Table 58. Global Brucella Abortus Vaccine Price by Application (2021-2026) & (US$/unit) Table 59. Global Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 60. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2027-2032) Table 61. Global Brucella Abortus Vaccine Sales by Application (2027-2032) & (US$ Million) Table 62. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2027-2032) Table 63. Global Brucella Abortus Vaccine Price by Application (2027-2032) & (US$/unit) Table 64. North America Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 65. North America Brucella Abortus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 67. Europe Brucella Abortus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Brucella Abortus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 71. Latin America Brucella Abortus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2021-2026) & (US$ Million) Table 74. Zoetis Company Information Table 75. Zoetis Business Overview Table 76. Zoetis Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Zoetis Brucella Abortus Vaccine Product Portfolio Table 78. Zoetis Recent Development Table 79. Qilu Animal Health Company Information Table 80. Qilu Animal Health Business Overview Table 81. Qilu Animal Health Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Qilu Animal Health Brucella Abortus Vaccine Product Portfolio Table 83. Qilu Animal Health Recent Development Table 84. Merck Animal Health Company Information Table 85. Merck Animal Health Business Overview Table 86. Merck Animal Health Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Merck Animal Health Brucella Abortus Vaccine Product Portfolio Table 88. Merck Animal Health Recent Development Table 89. Vetal Company Information Table 90. Vetal Business Overview Table 91. Vetal Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Vetal Brucella Abortus Vaccine Product Portfolio Table 93. Vetal Recent Development Table 94. VECOL Company Information Table 95. VECOL Business Overview Table 96. VECOL Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. VECOL Brucella Abortus Vaccine Product Portfolio Table 98. VECOL Recent Development Table 99. Tecnovax Company Information Table 100. Tecnovax Business Overview Table 101. Tecnovax Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Tecnovax Brucella Abortus Vaccine Product Portfolio Table 103. Tecnovax Recent Development Table 104. SYVA Laboratorios Company Information Table 105. SYVA Laboratorios Business Overview Table 106. SYVA Laboratorios Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio Table 108. SYVA Laboratorios Recent Development Table 109. Onderstepoort Biological Products Company Information Table 110. Onderstepoort Biological Products Business Overview Table 111. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio Table 113. Onderstepoort Biological Products Recent Development Table 114. Merial Company Information Table 115. Merial Business Overview Table 116. Merial Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Merial Brucella Abortus Vaccine Product Portfolio Table 118. Merial Recent Development Table 119. JOVAC Company Information Table 120. JOVAC Business Overview Table 121. JOVAC Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. JOVAC Brucella Abortus Vaccine Product Portfolio Table 123. JOVAC Recent Development Table 124. Instituto Rosenbusch Company Information Table 125. Instituto Rosenbusch Business Overview Table 126. Instituto Rosenbusch Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio Table 128. Instituto Rosenbusch Recent Development Table 129. Institute of Animal Health and Veterinary Biologicals Company Information Table 130. Institute of Animal Health and Veterinary Biologicals Business Overview Table 131. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio Table 133. Institute of Animal Health and Veterinary Biologicals Recent Development Table 134. Indian Immunologicals Company Information Table 135. Indian Immunologicals Business Overview Table 136. Indian Immunologicals Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Indian Immunologicals Brucella Abortus Vaccine Product Portfolio Table 138. Indian Immunologicals Recent Development Table 139. Hester Biosciences Company Information Table 140. Hester Biosciences Business Overview Table 141. Hester Biosciences Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Hester Biosciences Brucella Abortus Vaccine Product Portfolio Table 143. Hester Biosciences Recent Development Table 144. Dollvet Company Information Table 145. Dollvet Business Overview Table 146. Dollvet Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. Dollvet Brucella Abortus Vaccine Product Portfolio Table 148. Dollvet Recent Development Table 149. CZ Veterinaria Company Information Table 150. CZ Veterinaria Business Overview Table 151. CZ Veterinaria Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. CZ Veterinaria Brucella Abortus Vaccine Product Portfolio Table 153. CZ Veterinaria Recent Development Table 154. Colorado Serum Company Company Information Table 155. Colorado Serum Company Business Overview Table 156. Colorado Serum Company Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Colorado Serum Company Brucella Abortus Vaccine Product Portfolio Table 158. Colorado Serum Company Recent Development Table 159. CEVA Company Information Table 160. CEVA Business Overview Table 161. CEVA Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. CEVA Brucella Abortus Vaccine Product Portfolio Table 163. CEVA Recent Development Table 164. Centro Diagnostico Veterinario Company Information Table 165. Centro Diagnostico Veterinario Business Overview Table 166. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 167. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio Table 168. Centro Diagnostico Veterinario Recent Development Table 169. CAVAC Company Information Table 170. CAVAC Business Overview Table 171. CAVAC Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 172. CAVAC Brucella Abortus Vaccine Product Portfolio Table 173. CAVAC Recent Development Table 174. Biovet Company Information Table 175. Biovet Business Overview Table 176. Biovet Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 177. Biovet Brucella Abortus Vaccine Product Portfolio Table 178. Biovet Recent Development Table 179. Biogenesis Bago Company Information Table 180. Biogenesis Bago Business Overview Table 181. Biogenesis Bago Brucella Abortus Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 182. Biogenesis Bago Brucella Abortus Vaccine Product Portfolio Table 183. Biogenesis Bago Recent Development Table 184. North America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 185. North America Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 186. North America Brucella Abortus Vaccine Sales Market Share by Country (2021-2026) Table 187. North America Brucella Abortus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 188. North America Brucella Abortus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 189. North America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 190. North America Brucella Abortus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 191. North America Brucella Abortus Vaccine Market Share by Country (2021-2026) Table 192. North America Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 193. North America Brucella Abortus Vaccine Market Share Forecast by Country (2027-2032) Table 194. Europe Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 195. Europe Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 196. Europe Brucella Abortus Vaccine Sales Market Share by Country (2021-2026) Table 197. Europe Brucella Abortus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 198. Europe Brucella Abortus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 199. Europe Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 200. Europe Brucella Abortus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 201. Europe Brucella Abortus Vaccine Market Share by Country (2021-2026) Table 202. Europe Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 203. Europe Brucella Abortus Vaccine Market Share Forecast by Country (2027-2032) Table 204. Asia-Pacific Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 205. Asia-Pacific Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 206. Asia-Pacific Brucella Abortus Vaccine Sales Market Share by Country (2021-2026) Table 207. Asia-Pacific Brucella Abortus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 208. Asia-Pacific Brucella Abortus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 209. Asia-Pacific Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 210. Asia-Pacific Brucella Abortus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 211. Asia-Pacific Brucella Abortus Vaccine Market Share by Country (2021-2026) Table 212. Asia-Pacific Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 213. Asia-Pacific Brucella Abortus Vaccine Market Share Forecast by Country (2027-2032) Table 214. Latin America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 215. Latin America Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 216. Latin America Brucella Abortus Vaccine Sales Market Share by Country (2021-2026) Table 217. Latin America Brucella Abortus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 218. Latin America Brucella Abortus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 219. Latin America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. Latin America Brucella Abortus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 221. Latin America Brucella Abortus Vaccine Market Share by Country (2021-2026) Table 222. Latin America Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. Latin America Brucella Abortus Vaccine Market Share Forecast by Country (2027-2032) Table 224. Middle East and Africa Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 225. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 226. Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Country (2021-2026) Table 227. Middle East and Africa Brucella Abortus Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 228. Middle East and Africa Brucella Abortus Vaccine Sales Market Share Forecast by Country (2027-2032) Table 229. Middle East and Africa Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 230. Middle East and Africa Brucella Abortus Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 231. Middle East and Africa Brucella Abortus Vaccine Market Share by Country (2021-2026) Table 232. Middle East and Africa Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 233. Middle East and Africa Brucella Abortus Vaccine Market Share Forecast by Country (2027-2032) Table 234. Key Raw Materials Table 235. Raw Materials Key Suppliers Table 236. Brucella Abortus Vaccine Distributors List Table 237. Brucella Abortus Vaccine Customers List Table 238. Research Programs/Design for This Report Table 239. Authors List of This Report Table 240. Secondary Sources Table 241. Primary Sources List of Figures Figure 1. Brucella Abortus Vaccine Image Figure 2. Global Brucella Abortus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Abortus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Brucella Abortus Vaccine Sales (2021-2032) & (k units) Figure 5. Vector Vaccines Image Figure 6. Global Vector Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Subunit Vaccines Image Figure 8. Global Subunit Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. DNA Vaccines Image Figure 10. Global DNA Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 11. B. Abortus Recombinant Mutants Image Figure 12. Global B. Abortus Recombinant Mutants Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Brucella Abortus Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Brucella Abortus Vaccine Market Share by Type 2025 VS 2032 Figure 17. North America Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. North America Brucella Abortus Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Europe Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Europe Brucella Abortus Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Latin America Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Brucella Abortus Vaccine Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Brucella Abortus Vaccine Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Pigs Image Figure 30. Global Pigs Sales YoY Growth (2021-2032) & (k units) Figure 31. Sheep Image Figure 32. Global Sheep Sales YoY Growth (2021-2032) & (k units) Figure 33. Cattles Image Figure 34. Global Cattles Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Brucella Abortus Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Brucella Abortus Vaccine Market Share by Application 2025 VS 2032 Figure 39. North America Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. North America Brucella Abortus Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Europe Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Europe Brucella Abortus Vaccine Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Value by Application in 2025 Figure 45. Latin America Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Brucella Abortus Vaccine Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Value by Application in 2025 Figure 49. North America Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Brucella Abortus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Brucella Abortus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Brucella Abortus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Brucella Abortus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Brucella Abortus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Brucella Abortus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Brucella Abortus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Brucella Abortus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Brucella Abortus Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Brucella Abortus Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Brucella Abortus Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Brucella Abortus Vaccine Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Brucella Abortus Vaccine Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Vector Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • B. Abortus Recombinant Mutants
  • Others
Applications
  • Pigs
  • Sheep
  • Cattles
  • Others
Companies covered
  • Zoetis
  • Qilu Animal Health
  • Merck Animal Health
  • Vetal
  • VECOL
  • Tecnovax
  • SYVA Laboratorios
  • Onderstepoort Biological Products
  • Merial
  • JOVAC
  • Instituto Rosenbusch
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals
  • Hester Biosciences
  • Dollvet
  • CZ Veterinaria
  • Colorado Serum Company
  • CEVA
  • Centro Diagnostico Veterinario
  • CAVAC
  • Biovet
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brucella Abortus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Brucella Abortus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Brucella Abortus Vaccine Market by Type
  6. 1.3.1 Vector Vaccines
  7. 1.3.2 Subunit Vaccines
  8. 1.3.3 DNA Vaccines
  9. 1.3.4 B. Abortus Recombinant Mutants
  10. 1.3.5 Others
  11. 1.4 Global Brucella Abortus Vaccine Market Size by Type
  12. 1.4.1 Global Brucella Abortus Vaccine Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Brucella Abortus Vaccine Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Brucella Abortus Vaccine Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Brucella Abortus Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Brucella Abortus Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Brucella Abortus Vaccine Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Brucella Abortus Vaccine Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Brucella Abortus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Brucella Abortus Vaccine Industry Trends
  2. 2.2 Brucella Abortus Vaccine Industry Drivers
  3. 2.3 Brucella Abortus Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Abortus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Brucella Abortus Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Brucella Abortus Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Brucella Abortus Vaccine Price (2021-2026)
  4. 3.4 Global Brucella Abortus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brucella Abortus Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Brucella Abortus Vaccine Company, Product Type & Application
  7. 3.7 Global Brucella Abortus Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brucella Abortus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brucella Abortus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brucella Abortus Vaccine Tier 1, Tier 2, and Tier 3
4 Brucella Abortus Vaccine Regional Status and Outlook
  1. 4.1 Global Brucella Abortus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Brucella Abortus Vaccine Historic Market Size by Region
  3. 4.2.1 Global Brucella Abortus Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Brucella Abortus Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Brucella Abortus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Brucella Abortus Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Brucella Abortus Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Brucella Abortus Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Brucella Abortus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Brucella Abortus Vaccine by Application
  1. 5.1 Brucella Abortus Vaccine Market by Application
  2. 5.1.1 Pigs
  3. 5.1.2 Sheep
  4. 5.1.3 Cattles
  5. 5.1.4 Others
  6. 5.2 Global Brucella Abortus Vaccine Market Size by Application
  7. 5.2.1 Global Brucella Abortus Vaccine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Brucella Abortus Vaccine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Brucella Abortus Vaccine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Brucella Abortus Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Brucella Abortus Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Brucella Abortus Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Brucella Abortus Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Brucella Abortus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Qilu Animal Health
  8. 6.2.1 Qilu Animal Health Company Information
  9. 6.2.2 Qilu Animal Health Business Overview
  10. 6.2.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
  12. 6.2.5 Qilu Animal Health Recent Developments
  13. 6.3 Merck Animal Health
  14. 6.3.1 Merck Animal Health Company Information
  15. 6.3.2 Merck Animal Health Business Overview
  16. 6.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
  18. 6.3.5 Merck Animal Health Recent Developments
  19. 6.4 Vetal
  20. 6.4.1 Vetal Company Information
  21. 6.4.2 Vetal Business Overview
  22. 6.4.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vetal Brucella Abortus Vaccine Product Portfolio
  24. 6.4.5 Vetal Recent Developments
  25. 6.5 VECOL
  26. 6.5.1 VECOL Company Information
  27. 6.5.2 VECOL Business Overview
  28. 6.5.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 VECOL Brucella Abortus Vaccine Product Portfolio
  30. 6.5.5 VECOL Recent Developments
  31. 6.6 Tecnovax
  32. 6.6.1 Tecnovax Company Information
  33. 6.6.2 Tecnovax Business Overview
  34. 6.6.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
  36. 6.6.5 Tecnovax Recent Developments
  37. 6.7 SYVA Laboratorios
  38. 6.7.1 SYVA Laboratorios Company Information
  39. 6.7.2 SYVA Laboratorios Business Overview
  40. 6.7.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
  42. 6.7.5 SYVA Laboratorios Recent Developments
  43. 6.8 Onderstepoort Biological Products
  44. 6.8.1 Onderstepoort Biological Products Company Information
  45. 6.8.2 Onderstepoort Biological Products Business Overview
  46. 6.8.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
  48. 6.8.5 Onderstepoort Biological Products Recent Developments
  49. 6.9 Merial
  50. 6.9.1 Merial Company Information
  51. 6.9.2 Merial Business Overview
  52. 6.9.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merial Brucella Abortus Vaccine Product Portfolio
  54. 6.9.5 Merial Recent Developments
  55. 6.10 JOVAC
  56. 6.10.1 JOVAC Company Information
  57. 6.10.2 JOVAC Business Overview
  58. 6.10.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 JOVAC Brucella Abortus Vaccine Product Portfolio
  60. 6.10.5 JOVAC Recent Developments
  61. 6.11 Instituto Rosenbusch
  62. 6.11.1 Instituto Rosenbusch Company Information
  63. 6.11.2 Instituto Rosenbusch Business Overview
  64. 6.11.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
  66. 6.11.5 Instituto Rosenbusch Recent Developments
  67. 6.12 Institute of Animal Health and Veterinary Biologicals
  68. 6.12.1 Institute of Animal Health and Veterinary Biologicals Company Information
  69. 6.12.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  70. 6.12.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
  72. 6.12.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  73. 6.13 Indian Immunologicals
  74. 6.13.1 Indian Immunologicals Company Information
  75. 6.13.2 Indian Immunologicals Business Overview
  76. 6.13.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
  78. 6.13.5 Indian Immunologicals Recent Developments
  79. 6.14 Hester Biosciences
  80. 6.14.1 Hester Biosciences Company Information
  81. 6.14.2 Hester Biosciences Business Overview
  82. 6.14.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
  84. 6.14.5 Hester Biosciences Recent Developments
  85. 6.15 Dollvet
  86. 6.15.1 Dollvet Company Information
  87. 6.15.2 Dollvet Business Overview
  88. 6.15.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Dollvet Brucella Abortus Vaccine Product Portfolio
  90. 6.15.5 Dollvet Recent Developments
  91. 6.16 CZ Veterinaria
  92. 6.16.1 CZ Veterinaria Company Information
  93. 6.16.2 CZ Veterinaria Business Overview
  94. 6.16.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
  96. 6.16.5 CZ Veterinaria Recent Developments
  97. 6.17 Colorado Serum Company
  98. 6.17.1 Colorado Serum Company Company Information
  99. 6.17.2 Colorado Serum Company Business Overview
  100. 6.17.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
  102. 6.17.5 Colorado Serum Company Recent Developments
  103. 6.18 CEVA
  104. 6.18.1 CEVA Company Information
  105. 6.18.2 CEVA Business Overview
  106. 6.18.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 CEVA Brucella Abortus Vaccine Product Portfolio
  108. 6.18.5 CEVA Recent Developments
  109. 6.19 Centro Diagnostico Veterinario
  110. 6.19.1 Centro Diagnostico Veterinario Company Information
  111. 6.19.2 Centro Diagnostico Veterinario Business Overview
  112. 6.19.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
  114. 6.19.5 Centro Diagnostico Veterinario Recent Developments
  115. 6.20 CAVAC
  116. 6.20.1 CAVAC Company Information
  117. 6.20.2 CAVAC Business Overview
  118. 6.20.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 CAVAC Brucella Abortus Vaccine Product Portfolio
  120. 6.20.5 CAVAC Recent Developments
  121. 6.21 Biovet
  122. 6.21.1 Biovet Company Information
  123. 6.21.2 Biovet Business Overview
  124. 6.21.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Biovet Brucella Abortus Vaccine Product Portfolio
  126. 6.21.5 Biovet Recent Developments
  127. 6.22 Biogenesis Bago
  128. 6.22.1 Biogenesis Bago Company Information
  129. 6.22.2 Biogenesis Bago Business Overview
  130. 6.22.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
  132. 6.22.5 Biogenesis Bago Recent Developments
7 North America by Country
  1. 7.1 North America Brucella Abortus Vaccine Sales by Country
  2. 7.1.1 North America Brucella Abortus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Brucella Abortus Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Brucella Abortus Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Brucella Abortus Vaccine Market Size by Country
  6. 7.2.1 North America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Brucella Abortus Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Brucella Abortus Vaccine Sales by Country
  2. 8.1.1 Europe Brucella Abortus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Brucella Abortus Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Brucella Abortus Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Brucella Abortus Vaccine Market Size by Country
  6. 8.2.1 Europe Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Brucella Abortus Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Brucella Abortus Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Brucella Abortus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Brucella Abortus Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Brucella Abortus Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Brucella Abortus Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Brucella Abortus Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Brucella Abortus Vaccine Sales by Country
  2. 10.1.1 South America Brucella Abortus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Brucella Abortus Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Brucella Abortus Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Brucella Abortus Vaccine Market Size by Country
  6. 10.2.1 South America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Brucella Abortus Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Brucella Abortus Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Brucella Abortus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Brucella Abortus Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Brucella Abortus Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Brucella Abortus Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Brucella Abortus Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Brucella Abortus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Brucella Abortus Vaccine Value Chain Analysis
  2. 12.1.1 Brucella Abortus Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Brucella Abortus Vaccine Production Mode & Process
  7. 12.2 Brucella Abortus Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Brucella Abortus Vaccine Distributors
  10. 12.2.3 Brucella Abortus Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst